Mayne Pharma Group Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Mar 24 | BuyUS$995,456 | UBS Asset Management AG | Company | 217,138 | US$4.58 | |
14 Mar 24 | SellUS$1,425,107 | UBS Asset Management AG | Company | 311,656 | US$4.57 | |
08 Mar 24 | BuyUS$126,827 | UBS Asset Management AG | Company | 27,522 | US$4.64 | |
08 Mar 24 | SellUS$213,676 | UBS Asset Management AG | Company | 46,490 | US$4.62 | |
07 Mar 24 | BuyUS$1,841,699 | UBS Asset Management AG | Company | 399,486 | US$4.61 | |
07 Mar 24 | BuyUS$205,970 | Credit Suisse Asset Management (Switzerland) Ltd. | Company | 44,430 | US$4.64 | |
07 Mar 24 | SellUS$2,605,673 | UBS Asset Management AG | Company | 567,908 | US$4.59 | |
01 Mar 24 | BuyUS$3,415,118 | UBS Asset Management AG | Company | 797,712 | US$4.28 | |
01 Mar 24 | SellUS$2,889,953 | UBS Asset Management AG | Company | 673,765 | US$4.29 | |
26 Feb 24 | BuyUS$1,809,136 | UBS Asset Management AG | Company | 459,566 | US$3.94 | |
26 Feb 24 | SellUS$889,391 | UBS Asset Management AG | Company | 227,471 | US$3.91 | |
23 Feb 24 | BuyUS$23,947,310 | UBS Asset Management AG | Company | 6,915,901 | US$3.46 | |
23 Feb 24 | SellUS$21,447,514 | UBS Asset Management AG | Company | 6,192,570 | US$3.46 | |
12 Dec 23 | BuyUS$17,600,992 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 4,682,116 | US$3.76 | |
01 Dec 23 | BuyUS$25,843 | Frank Condella | Individual | 7,154 | US$3.61 | |
31 Oct 23 | BuyUS$12,571,016 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 5,250,334 | US$2.39 | |
31 Oct 23 | SellUS$22,833,499 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 9,620,038 | US$2.37 | |
25 Oct 23 | BuyUS$43,783 | Kathryn MacFarlane | Individual | 18,000 | US$2.43 | |
24 Oct 23 | BuyUS$89,448 | Shawn O’Brien | Individual | 37,041 | US$2.41 | |
23 Oct 23 | BuyUS$26,019 | Ann Custin | Individual | 12,287 | US$2.12 | |
02 Aug 23 | SellUS$8,007 | Goldman Sachs Asset Management, L.P. | Company | 2,658 | US$3.01 | |
24 Jul 23 | BuyUS$3,304,049 | Viburnum Funds Pty Ltd. | Company | 1,123,793 | US$2.94 | |
23 Jun 23 | BuyUS$425,501 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 162,392 | US$2.62 | |
23 Jun 23 | SellUS$317,492 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 120,527 | US$2.67 | |
21 Jun 23 | SellUS$11,040,042 | Mithra Pharmaceuticals SA | Company | 4,221,815 | US$2.61 | |
19 Jun 23 | BuyUS$17,445,885 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 7,470,185 | US$2.34 | |
16 Jun 23 | BuyUS$887,644 | Blackstone Inc. | Company | 341,518 | US$2.60 | |
16 Jun 23 | BuyUS$887,644 | Blackstone Alternative Asset Management L.P. | Company | 341,518 | US$2.60 | |
13 Jun 23 | SellUS$73,957 | Lazard Asset Management LLC | Company | 27,714 | US$2.67 | |
30 May 23 | BuyUS$2,028,200 | Viburnum Funds Pty Ltd. | Company | 874,278 | US$2.32 | |
29 May 23 | BuyUS$7,112 | Lazard Asset Management LLC | Company | 2,891 | US$2.46 | |
23 May 23 | BuyUS$79,971 | Lazard Asset Management LLC | Company | 32,937 | US$2.43 | |
19 May 23 | SellUS$3,110,607 | Lazard Asset Management LLC | Company | 1,247,552 | US$2.49 | |
11 May 23 | BuyUS$158,860 | Lazard Asset Management LLC | Company | 60,769 | US$2.61 | |
08 May 23 | BuyUS$1,410,603 | Viburnum Funds Pty Ltd. | Company | 511,541 | US$2.76 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 4,221,815 | 5.2% |
Private Companies | 4,760,319 | 5.87% |
VC/PE Firms | 6,428,268 | 7.92% |
Individual Insiders | 8,409,404 | 10.4% |
Institutions | 26,781,679 | 33% |
General Public | 30,546,474 | 37.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,428,268 | US$29.1m | 0% | 8.64% | |||
5,292,066 | US$24.0m | 0% | no data | |||
5,218,110 | US$23.6m | -6.84% | 0.01% | |||
4,240,774 | US$19.2m | 0% | 0.02% | |||
4,221,815 | US$19.1m | 0% | no data | |||
3,700,223 | US$16.8m | 0% | 0.55% | |||
3,389,914 | US$15.4m | 0% | 4.26% | |||
3,354,047 | US$15.2m | 0.28% | no data | |||
1,889,905 | US$8.6m | 36.6% | no data | |||
1,701,480 | US$7.7m | 0% | 0.01% | |||
1,295,569 | US$5.9m | 0% | no data | |||
1,283,206 | US$5.8m | 2.7% | no data | |||
1,280,210 | US$5.8m | 0% | no data | |||
800,000 | US$3.6m | 0% | no data | |||
750,000 | US$3.4m | 0% | no data | |||
556,697 | US$2.5m | -33% | no data | |||
522,028 | US$2.4m | 0% | no data | |||
500,000 | US$2.3m | 0% | no data | |||
465,000 | US$2.1m | 0% | no data | |||
400,000 | US$1.8m | 0% | no data | |||
374,563 | US$1.7m | 0% | no data | |||
365,626 | US$1.7m | 0% | no data | |||
354,500 | US$1.6m | 0% | no data | |||
341,518 | US$1.5m | 0% | 0.01% | |||
314,685 | US$1.4m | 0% | 0.96% |